Are you a researcher looking to promote your psychedelic-related trials or studies? The Australian Psychedelic Society is here to help! We welcome you to share your research opportunities with our community. To have your study featured on our website, please email the following information to research@psychedelicsociety.org.au:

Research Project Title: Exploring the impact of hallucinogenic drugs on OCD related symptoms.

Chief Investigator: Dr Vince Polito

Associate Investigators: Professor Melissa Norberg, Dr Christina Perry, Ms Dora Szabo

My experiences are vastly different from some of Australia’s first clients to receive legal clinical psychedelic-assisted therapy (PAT), these individuals went through the controversially expensive above-ground treatments (legal drugs with approved therapists, that the government knows about—no sneaking around for these guys). I have had the pleasure of working with some of them on their ongoing integration program, which eventually will end, and these clients will be left to navigate their changing perspectives and inner worlds on their own.

We are looking for passionate individuals to raise awareness of the Australian Psychedelic Society and its initiatives. Your dedication to promoting responsible psychedelic use and fostering a supportive community is crucial to our mission's success.

Volunteer with the Australian Psychedelic Society. Be a part of Australia's Psychedelic Story.

In recent years we've observed various issues arising from the psychedelic underground and potential for issues in the emerging clinical frameworks. From safety concerns to ethical considerations, it's clear that proper guidance is essential for those embarking on psychedelic journeys. That's where the role of a knowledgeable and experienced guide becomes indispensable.

Breaking the silences and delving deeper into the culture of avoidance within the psychedelics community regarding allegations against Ben Sessa.

“The idea of ‘giving the drug war more arguments to exist’ is a common retort in the psychedelics world used to shut down people who speak about abuses.” - Kayla Greenstein

This quote hits home, highlighting how discussions about misconduct and abuses are often met with dismissal or defensiveness.

Seeking Participants for Psychedelic Research

The aims of decriminalisation, legalisation, and safe supply are themselves part of a larger conversation around the future of how our health system can help people flourish and how society can better respect bodily autonomy, cognitive liberty, and religious freedoms.

And we have to start somewhere, and for us, that’s here.

- Dr Sam Douglas

Microdosing refers to the practice of taking very low doses of psychedelics, which do not trigger any hallucinatory effects, commonly known as “sub-perceptual doses”. This is often highly personalised, with exact dosages and frequency differing from person to person. Some people report long-lasting effects from just one month of microdosing, while others microdose for several months at a time.

Intention and expectation: Understanding these distinctions allows individuals to approach psychedelic experiences with a balanced mindset, acknowledging both the purposeful intent and the natural human inclination to anticipate outcomes.